U.S. Household Products Stock News

NYSE:CPNG
NYSE:CPNGMultiline Retail

Coupang (CPNG) Q4 Loss Highlights Fragile Margins Behind Bullish Earnings Narratives

Coupang FY 2025 Results Set Up a Mixed but Margin Focused Story Coupang (CPNG) closed FY 2025 with fourth quarter revenue of US$8.8b and a basic EPS loss of US$0.01, as net income excluding extra items came in at a US$26m loss against a backdrop of growing full year scale. The company has seen quarterly revenue step up from US$7.9b in Q4 2024 to between US$7.9b and US$9.3b through 2025. Basic EPS has moved between a profit of US$0.06 and a small loss in the latest quarter, setting up a TTM...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Opera (OPRA) One Off Gain Clouds Strong FY 2025 Profit Growth Narrative

Opera (NasdaqGS:OPRA) posts FY 2025 results Opera (NasdaqGS:OPRA) closed out FY 2025 with fourth quarter revenue of US$176.7 million and basic EPS of US$0.62, rounding off a trailing twelve month run of US$614.4 million in revenue and EPS of US$1.21 as earnings grew 34.1% over the past year. The company has seen revenue move from US$480.6 million on a trailing basis at the end of 2024 to US$614.4 million by the end of 2025, while trailing net profit margin edged up from 16.8% to 17.6%. With...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Innodata (INOD) Margin Compression Challenges Bullish AI Growth Narrative After FY 2025 Results

Innodata (INOD) has just wrapped up FY 2025 with fourth quarter revenue of US$72.4 million and basic EPS of US$0.28, alongside trailing twelve month revenue of US$251.7 million and EPS of US$1.01. The company has seen quarterly revenue move from US$52.2 million in Q3 2024 to US$72.4 million in Q4 2025. Basic EPS has ranged from US$0.60 in Q3 2024 to between US$0.23 and US$0.28 across the 2025 quarters, setting up a picture where growing sales are rubbing against tighter margins and leaving...
NYSE:ONON
NYSE:ONONLuxury

On Holding Weighs Asia Pacific Push Against Margin And Execution Risks

On Holding (NYSE:ONON) is expanding rapidly across Asia-Pacific, adding new markets and strengthening its regional presence. The company is pushing its direct-to-consumer model globally, supported by its own performance footwear and apparel technology. Management is putting capital behind product development and customer engagement, with an eye on premium brand positioning worldwide. On Holding, trading at around $46.48, sits in a premium corner of the sportswear space with a 3 year return...
NYSE:PLD
NYSE:PLDIndustrial REITs

Is Prologis (PLD) Pricing In Too Much Optimism After Its Strong Multi Year Run?

If you are wondering whether Prologis at around US$142.57 is priced for perfection or offering value, you are in the right place for a clear look at what the current share price might imply. The stock has recent returns of 0.7% over 7 days, 12.1% over 30 days, 10.5% year to date, 19.1% over 1 year, 23.5% over 3 years and 68.4% over 5 years. This naturally raises questions about how much optimism is already reflected in the price. Recent attention around Prologis has focused on its role as a...
NYSE:CTRA
NYSE:CTRAOil and Gas

Coterra Energy (CTRA) Margin Improvement To 23.5% Tests Bearish Gas Price Concerns

Coterra Energy FY 2025 Earnings Snapshot Coterra Energy (CTRA) closed FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$0.48, alongside net income excluding extra items of US$368 million, giving investors a clear read on its latest top and bottom line. Over the past year, the company has seen trailing twelve month revenue move from US$5.2 billion to US$7.3 billion, while trailing EPS shifted from US$1.51 to US$2.26 as net income excluding extra items moved from US$1.1...
NYSE:PNW
NYSE:PNWElectric Utilities

Pinnacle West Credit Facility Extends Liquidity While Valuation Appears Stretched

Pinnacle West Capital (NYSE:PNW) entered a new $300 million revolving credit facility, replacing its prior arrangement. The facility extends through 2031 and is intended to support general corporate purposes and ongoing infrastructure investments. For investors watching NYSE:PNW, this fresh $300 million credit line arrives with the stock around $100.3 per share, alongside returns of 13.8% year to date and 63.9% over 5 years. These figures provide a snapshot of how the market has valued the...
NYSE:MMM
NYSE:MMMIndustrials

Is 3M (MMM) Pricing In Its Legal Risks After Recent Share Price Gains

If you are wondering whether 3M is still a solid value play at its current price, this article walks through what the numbers actually say about the stock. 3M shares last closed at US$165.32, with a 1% decline over the past week, a 6% gain over the last 30 days, and returns of 2.2% year to date, 8.5% over 1 year, a very large gain over 3 years, and 31% over 5 years. Recent headlines around 3M have focused on its ongoing business repositioning and legal overhangs, which continue to shape how...
NYSE:PERF
NYSE:PERFSoftware

Assessing Perfect Corp (NYSE:PERF) Valuation After LashLovr Partnership And Recent Earnings

Perfect (PERF) has drawn fresh attention after partnering with True Beauty Lashes on LashLovr, an AI powered lash matching and virtual try on experience that highlights how its APIs are used in real retail journeys. See our latest analysis for Perfect. Even with the LashLovr partnership and recent earnings update, Perfect’s short term share price return has been weak, with a 30 day share price decline of 18.67% and a 1 year total shareholder return of 28.19% in the red. This points to fading...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Perrigo Cost Reset Program Faces Impairment Hit And Transition Year

Perrigo (NYSE:PRGO) has announced a new operational enhancement program after reporting significant progress on its Three-S transformation approach. The company highlighted a tripling in the value of its innovation pipeline and more than US$100 million in new distribution wins. Perrigo also reported a major net loss for the fourth quarter and full year, linked in part to an asset impairment charge. Management described 2026 as a transition year, citing manufacturing under-absorption, and is...
NasdaqGS:LASR
NasdaqGS:LASRElectronic

NLIGHT (LASR) Narrower Q4 EPS Loss Tests Bullish Turnaround Narrative

nLIGHT (LASR) has wrapped up FY 2025 with Q4 revenue of US$81.2 million and a basic EPS loss of US$0.10, alongside trailing twelve month revenue of US$261.3 million and a basic EPS loss of US$0.47. The company has seen quarterly revenue move from US$47.4 million in Q4 2024 to US$81.2 million in Q4 2025, while basic EPS over the same quarters shifted from a loss of US$0.51 to a loss of US$0.10. This leaves investors to weigh growth expectations against still negative margins and the path to...
NYSE:NHI
NYSE:NHIHealth Care REITs

National Health Investors (NHI) FFO Growth Challenges Bearish Margin And Tenant Risk Narratives

National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for healthcare REIT investors. The company reported quarterly revenue of US$85.8 million in Q4 2024 and US$107.5 million in Q4 2025, while basic EPS moved from US$0.96 to US$0.80 over the same period, providing a view of how the top line and earnings per share have developed into the latest release...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Zscaler Q2 Loss Deepens To US$0.21 EPS And Tests Profitability Narratives

Fresh off its Q2 2026 print, Zscaler (ZS) reported revenue of US$815.8 million and a basic EPS loss of US$0.21, with net income excluding extra items at a loss of US$34.3 million, setting the tone for how investors will read the quarter. The company has seen revenue move from US$647.9 million in Q2 2025 through to US$815.8 million in Q2 2026, while quarterly basic EPS over that stretch has ranged from a loss of US$0.05 in Q2 2025 to a loss of US$0.21 in the latest quarter. As a result, the...
NasdaqGS:SDGR
NasdaqGS:SDGRHealthcare Services

Does Schrödinger’s 2025 Revenue Surge And Narrower Loss Reshape The Bull Case For SDGR?

Schrödinger, Inc. reported full-year 2025 results, with sales of US$56.37 million and total revenue of US$255.87 million, while reducing its net loss to US$103.27 million and basic loss per share from continuing operations to US$1.41. The combination of strong revenue growth and a substantially smaller loss suggests the company is scaling its platform while exercising tighter cost control. We’ll now examine how this sharp revenue increase and narrower loss shape Schrödinger’s existing...
NYSE:SQM
NYSE:SQMChemicals

Is Sociedad Química y Minera de Chile (NYSE:SQM) Pricing Reflect Longer Term Lithium Demand Outlook?

If you are wondering whether Sociedad Química y Minera de Chile shares are still offering value at current levels, this article is here to unpack what the current price might be implying about the business. The stock last closed at US$76.30, with a 6.2% return over the past 7 days, a 9.4% return year to date, a 98.9% return over 1 year, a 71.6% return over 5 years and an 8.7% decline over 30 days. This can naturally raise questions about where expectations and risks now sit. Recent headlines...
NYSE:PH
NYSE:PHMachinery

Is Parker-Hannifin (PH) Still Attractive After Its 52% One-Year Share Price Surge?

If you are wondering whether Parker-Hannifin's current share price still offers value, this article walks through what the numbers are saying about the stock today. The shares recently closed at US$1,009.18, with returns of 10.1% over the last 30 days, 12.9% year to date, and 52.4% over 1 year, while the 3 year and 5 year returns sit at 190.3% and 259.2% respectively. This follows a 1.3% decline over the past week. Recent coverage has focused on Parker-Hannifin as a large US capital goods...
NYSE:KMX
NYSE:KMXSpecialty Retail

CarMax Bets On ChatGPT Vehicle App To Reignite Digital Growth Narrative

CarMax, NYSE:KMX, has launched a vehicle shopping app in the ChatGPT app store, positioning itself as the first U.S. auto retailer to offer a dedicated conversational AI car buying and selling experience. The new app allows users to search, compare, and explore CarMax’s nationwide inventory using natural language directly within ChatGPT. The move is aimed at aligning the car buying process with changing consumer habits around digital and AI assisted shopping. CarMax enters this launch with...
NasdaqGM:SUPN
NasdaqGM:SUPNPharmaceuticals

Supernus Pharmaceuticals Record Revenues And New CNS Drugs Prompt Valuation Questions

Supernus Pharmaceuticals reported record revenues in 2025. The company completed the integration of Sage Therapeutics. New products ONAPGO for Parkinson's disease and ZURZUVAE for postpartum depression were launched. The business expanded into new therapeutic areas despite supply constraints. For investors looking at NasdaqGM:SUPN, these company updates come with a stock that last closed at $54.73 and has returned 70.7% over the past year. Over 3 years the stock is up 37.5%, and over 5...
NasdaqGS:TRMK
NasdaqGS:TRMKBanks

Is It Time To Reconsider Trustmark (TRMK) After A 19% One Year Share Price Gain

If you are wondering whether Trustmark's current share price lines up with its underlying value, this article is designed to walk you through that question in a clear, practical way. Trustmark's share price recently closed at US$42.59, with returns of a 4.8% decline over 7 days, 1.1% over 30 days, 9.0% year to date, 19.3% over 1 year, 59.7% over 3 years and 48.4% over 5 years. These price moves are sitting against a backdrop of ongoing interest in US regional banks. In this space, investors...
NasdaqGS:RUN
NasdaqGS:RUNElectrical

Sunrun (RUN) Profit Swing To US$450 Million TTM Challenges Bearish Cash Flow Narratives

Sunrun (RUN) closed out FY 2025 with Q4 revenue of US$1.2 billion and basic EPS of US$0.45, while trailing twelve month EPS sat at US$1.96 on revenue of US$3.0 billion. The company has seen quarterly revenue range from US$504.3 million to US$1.2 billion through 2025, with basic EPS moving from US$0.22 in Q1 to US$1.22 in Q2 and US$0.07 in Q3 before landing at US$0.45 in Q4, alongside a trailing twelve month net income of US$449.9 million. For investors, the key question now is how durable...
NasdaqGS:AMRX
NasdaqGS:AMRXPharmaceuticals

Amneal Pharmaceuticals (AMRX) Return To Profit Tests High 60.3x P/E Narrative

Amneal Pharmaceuticals (AMRX) has just posted its FY 2025 numbers, with Q4 revenue of US$814.3 million and basic EPS of US$0.11, capping a trailing twelve month run of US$3.0 billion in revenue and EPS of US$0.23. Over recent quarters the company has seen revenue move from US$702.5 million in Q3 2024 to US$730.5 million in Q4 2024, then to US$695.4 million, US$724.5 million, US$784.5 million and finally US$814.3 million through FY 2025, while quarterly EPS shifted from a loss of US$0.10 to...
NYSE:DBRG
NYSE:DBRGCapital Markets

DigitalBridge Results Raise Questions As Guidance Pauses For SoftBank Proposal

DigitalBridge Group (NYSE:DBRG) released its latest quarterly financial results and paused regular quarterly guidance. The company decided not to host its usual earnings call, citing a proposed transaction with SoftBank Group Corp. The SoftBank proposal could lead to meaningful changes in DigitalBridge Group's business structure or ownership. DigitalBridge Group, a digital infrastructure investment firm, operates at the intersection of data centers, connectivity and related assets that...
NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Is It Too Late To Consider Ouster (OUST) After Its Sharp One Year Rebound?

Wondering if Ouster at around US$18.95 is still offering value after a volatile few years, or if most of the easy upside is already reflected in the price. The stock has been on a wild ride, with a 1.8% gain over the last 7 days, a 20.6% decline over 30 days, an 18.9% decline year to date, a 129.7% return over 1 year and a 69.2% return over 3 years, compared with an 84.2% decline over 5 years. Recent news coverage around Ouster has largely focused on its role in the lidar and sensor space...
NasdaqGS:SYBT
NasdaqGS:SYBTBanks

Is It Time To Revisit Stock Yards Bancorp (SYBT) After Recent Share Price Weakness

If you are wondering whether Stock Yards Bancorp is attractively priced or just fairly valued at its current level, you are in the right place. The share price closed at US$64.14, with returns of a 7.5% decline over 7 days, a 5.2% decline over 30 days, a 1.6% decline year to date, and a 10.4% decline over 1 year, set against gains of 18.1% over 3 years and 31.9% over 5 years. These mixed returns give investors several entry and exit points to think about, especially if you are weighing...